Literature DB >> 20523024

Pharmacologic neuroimaging of the ontogeny of dopamine receptor function.

Y Iris Chen1, Ji-Kyung Choi, Haibo Xu, Jiaqian Ren, Susan L Andersen, Bruce G Jenkins.   

Abstract

Characterization of the ontogeny of the cerebral dopaminergic system is crucial for gaining a greater understanding of normal brain development and its alterations in response to drugs of abuse or conditions such as attention-deficit hyperactivity disorder. Pharmacological MRI (phMRI) was used to determine the response to dopamine transporter (DAT) blockers cocaine and methylphenidate (MPH), the dopamine releaser D-amphetamine (AMPH), the selective D1 agonist dihydrexidine, and the D2/D3 agonist quinpirole in young (<30 days old) and adult (>60 days old) rats. In adult rats, cocaine (0.5 mg/kg i.v.) or MPH (2 mg/kg) induced primarily positive cerebral blood volume (rCBV) changes in the dopaminergic circuitry, but negative rCBV changes in the young animals. Microdialysis measurements in the striatum showed that young rats have a smaller increase in extracellular dopamine in response to cocaine than adults. The young rats showed little rCBV response to the selective D1 agonist dihydrexidine in contrast to robust rCBV increases observed in the adults, whereas there was a similar negative rCBV response in the young and adult rats to the D2 agonist quinpirole. We also performed a meta-analysis of literature data on the development of D1 and D2 receptors and the DAT. These data suggest a predominance of D2-like over D1-like function between 20 and 30 days of age. These combined results suggested that the dopamine D1 receptor is functionally inhibited at young age. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523024      PMCID: PMC2919511          DOI: 10.1159/000286215

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  85 in total

1.  Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period.

Authors:  C A Moody; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Ontogeny of biphasic locomotor effects of quinpirole.

Authors:  C Van Hartesveldt; M E Meyer; T J Potter
Journal:  Pharmacol Biochem Behav       Date:  1994-07       Impact factor: 3.533

3.  Regional patterns of cholinergic and glutamate activity in the developing and aging human brain.

Authors:  J A Court; E K Perry; M Johnson; M A Piggott; J A Kerwin; R H Perry; P G Ince
Journal:  Brain Res Dev Brain Res       Date:  1993-07-16

4.  Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.

Authors:  C A Moody; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.

Authors:  M H Teicher; N I Barber; H A Gelbard; A L Gallitano; A Campbell; E Marsh; R J Baldessarini
Journal:  Neuropsychopharmacology       Date:  1993-09       Impact factor: 7.853

6.  Ontogeny of dopamine D2 receptor mRNA in rat brain.

Authors:  L K Srivastava; M A Morency; R K Mishra
Journal:  Eur J Pharmacol       Date:  1992-02-13       Impact factor: 4.432

7.  Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.

Authors:  C A Crawford; J K Rowlett; S A McDougall; M T Bardo
Journal:  Eur J Pharmacol       Date:  1994-02-03       Impact factor: 4.432

8.  Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.

Authors:  S A McDougall; C A Crawford; A J Nonneman
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  The development of D2 autoreceptor-mediated modulation of K(+)-evoked dopamine release in the neostriatum.

Authors:  S L Andersen; R A Gazzara
Journal:  Brain Res Dev Brain Res       Date:  1994-03-18

10.  Monocrystalline iron oxide nanocompounds (MION): physicochemical properties.

Authors:  T Shen; R Weissleder; M Papisov; A Bogdanov; T J Brady
Journal:  Magn Reson Med       Date:  1993-05       Impact factor: 4.668

View more
  28 in total

1.  Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.

Authors:  J Rouine; M E Kelly; C Jennings-Murphy; P Duffy; I Gorman; S Gormley; C M Kerskens; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2014-11-01       Impact factor: 4.530

Review 2.  GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studies.

Authors:  Marisa M Silveri
Journal:  Pharmacol Ther       Date:  2014-03-11       Impact factor: 12.310

Review 3.  News and views on in-vivo imaging of neurotransmission using PET and MRI.

Authors:  Christin Y Sander; Swen Hesse
Journal:  Q J Nucl Med Mol Imaging       Date:  2017-07-27       Impact factor: 2.346

Review 4.  Adolescent alcohol exposure: Are there separable vulnerable periods within adolescence?

Authors:  Linda Patia Spear
Journal:  Physiol Behav       Date:  2015-01-23

5.  Abstinence to chronic methamphetamine switches connectivity between striatal, hippocampal and sensorimotor regions and increases cerebral blood volume response.

Authors:  Ji-Kyung Choi; Grewo Lim; Yin-Ching Iris Chen; Bruce G Jenkins
Journal:  Neuroimage       Date:  2018-03-05       Impact factor: 6.556

Review 6.  Data collection and analysis strategies for phMRI.

Authors:  Joseph B Mandeville; Christina H Liu; Wim Vanduffel; John J A Marota; Bruce G Jenkins
Journal:  Neuropharmacology       Date:  2014-03-05       Impact factor: 5.250

7.  Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism.

Authors:  Jasmin M Dao; Susan C McQuown; Sandra E Loughlin; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

8.  Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response.

Authors:  Celina Y Mojica; Jasmin M Dao; Menglu Yuan; Sandra E Loughlin; Frances M Leslie
Journal:  Neuropharmacology       Date:  2013-10-22       Impact factor: 5.250

Review 9.  The effects of abused drugs on adolescent development of corticolimbic circuitry and behavior.

Authors:  J M Gulley; J M Juraska
Journal:  Neuroscience       Date:  2013-05-24       Impact factor: 3.590

Review 10.  Nicotine, adolescence, and stress: A review of how stress can modulate the negative consequences of adolescent nicotine abuse.

Authors:  Erica Holliday; Thomas J Gould
Journal:  Neurosci Biobehav Rev       Date:  2016-04-08       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.